DMAAU
Drugs Made In America Acquisition Corp. Units
NASDAQ · Financial Services · Financial - Conglomerates · US
$10.83
+0.37%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
4.4%
Return on equity
4.1%
Return on assets
-1.9%
Return on invested capital
0.00x
Asset turnover
-$323.1K
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026